USA
This article was added by the user . TheWorldNews is not responsible for the content of the platform.

The FDA allows licensed pharmacists to prescribe Pfizer's Paxlovid under certain conditions.

(CNN)US Food and Drug Administrationgrants Pfizer an emergency use authorization for Covid-19 antiviralsRevised Treatment, Paxlovid, allows state-licensed pharmacists to prescribe treatment to qualified people on Wednesday.

"The FDA recognizes and continues to play an important role for pharmacists in the fight against this pandemic," said Patrizia, director of the FDA's Center for Drug Evaluation and Research. Dr. Cavazzoni said in a statement. "Because you need to take Paxrovid within 5 days of the onset of symptoms, you are eligible to take this drug for the treatment of COVID-19 by allowing a nationally licensed pharmacist to prescribe Paxrovid. You can increase access to timely treatment for some patients with. ”

Those who test positive for Covid-19 first meet or provide a regular care provider. You should consider finding a localtest-to-treatsite where you can get your prescription from someone. The FDA said.

Those who want to get Paxrovid from a pharmacist must be younger than 12 months and have an electronic or printed health record and list containing blood tests to check for kidney and liver problems. there is. Breakdown of all medications taken with both over-the-counter and prescription medications to screen for drug interactions. Health records can also be obtained through consultation between the pharmacist and the individual health care provider.

The FDA states that the revised EUA has some restrictions to ensure proper evaluation and prescribing. The pharmacist will tell you if there is not enough evidence to check for kidney function, liver function, or potential drug interactions, if other medications need to be changed, or if Paxlovid is not the appropriate treatment. You need to introduce people to medical providers such as.

Paxlovid is a positive Covid-19 test and is permitted to treat mild to moderate Covid-19 over the age of 12 with a high risk of severe Covid.

Antivirals were granted aEmergency Use Authorizationin December. In May, Pfizer announced that it had submitteda complete FDA approval application for Paxrovid.

About one-third of the U.S. population lives in "high Covid-19 community-level" counties, and the Centers for Disease Control and Prevention recommends universal indoor masking and extra medical systems. Risk of burden. Covid-19 hospitalizations are also slowly increasing nationwide, according to data from the US Department of Health and Human Services.